These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38692486)

  • 1. Successful pediatric inpatient penicillin allergy delabeling through direct oral challenges.
    Ray KM; Vyles DE; Zembles TN; Mitchell ML
    J Allergy Clin Immunol Pract; 2024 Aug; 12(8):2193-2195. PubMed ID: 38692486
    [No Abstract]   [Full Text] [Related]  

  • 2. Updates to penicillin allergy delabeling: Reducing the need for direct testing.
    Brown JF; Kim J; Ham Y; Joshi SR
    Ann Allergy Asthma Immunol; 2024 May; 132(5):656-657. PubMed ID: 38219872
    [No Abstract]   [Full Text] [Related]  

  • 3. Linking the Who, What, When, and Where of Inpatient Direct Oral Penicillin Challenge With the How of Durable Penicillin Allergy Delabeling.
    Olans RN; Olans RD
    Clin Infect Dis; 2024 Jan; 78(1):227. PubMed ID: 37585654
    [No Abstract]   [Full Text] [Related]  

  • 4. Direct amoxicillin challenge without preliminary skin testing for pediatric patients with penicillin allergy labels.
    Wang LA; Patel K; Kuruvilla ME; Shih J
    Ann Allergy Asthma Immunol; 2020 Aug; 125(2):226-228. PubMed ID: 32407949
    [No Abstract]   [Full Text] [Related]  

  • 5. Inpatient allergy delabeling of pediatric patients with low-risk penicillin allergy status through direct oral amoxicillin challenge.
    Lim PPC; Moore LN; Minich NM; Wessell KR; Desai AP
    Allergy Asthma Proc; 2024 Jan; 45(1):61-69. PubMed ID: 38151739
    [No Abstract]   [Full Text] [Related]  

  • 6. Durability of penicillin allergy delabeling and post-testing penicillin utilization in adults with immune compromise.
    Rose MT; Mitri EA; Vogrin S; Holmes NE; Chua KYL; Slavin MA; Trubiano JA
    J Allergy Clin Immunol Pract; 2024 Jul; 12(7):1928-1930.e1. PubMed ID: 38582191
    [No Abstract]   [Full Text] [Related]  

  • 7. Caregiver perceptions on pediatric penicillin allergy delabeling in a primary care setting.
    Lee HJ; Hart M; Chow TG
    Ann Allergy Asthma Immunol; 2024 Sep; 133(3):349-351. PubMed ID: 38879164
    [No Abstract]   [Full Text] [Related]  

  • 8. Single dose amoxicillin challenges are safe for the evaluation of pediatric penicillin allergy.
    Wang LA; Hicks A; Bauer M; Carel K
    Ann Allergy Asthma Immunol; 2024 Oct; 133(4):480-481. PubMed ID: 39038703
    [No Abstract]   [Full Text] [Related]  

  • 9. Delabeling penicillin allergy in a pediatric primary care clinic.
    Chow TG; Patel G; Mohammed M; Johnson D; Khan DA
    Ann Allergy Asthma Immunol; 2023 May; 130(5):667-669. PubMed ID: 36738783
    [No Abstract]   [Full Text] [Related]  

  • 10. Feedback on "Delabeling penicillin allergy in a pediatric primary care clinic".
    McLaughlin D
    Ann Allergy Asthma Immunol; 2023 May; 130(5):673. PubMed ID: 37137604
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and efficacy of direct two-step penicillin challenges with an inpatient pharmacist-driven allergy evaluation.
    Ham Y; Sukerman ES; Lewis JS; Tucker KJ; Yu DL; Joshi SR
    Allergy Asthma Proc; 2021 Mar; 42(2):153-159. PubMed ID: 33685561
    [No Abstract]   [Full Text] [Related]  

  • 12. Direct oral penicillin challenge for penicillin allergy delabeling as a health services intervention: A multicenter cohort study.
    Trubiano JA; Vogrin S; Copaescu A; Nasra M; Douglas A; Holmes NE; Chua KYL
    Allergy; 2022 Mar; 77(3):1038-1042. PubMed ID: 34735748
    [No Abstract]   [Full Text] [Related]  

  • 13. Penicillin allergy delabeling: Opportunities for implementation and dissemination.
    Samarakoon U; Accarino J; Wurcel AG; Jaggers J; Judd A; Blumenthal KG
    Ann Allergy Asthma Immunol; 2023 May; 130(5):554-564. PubMed ID: 36563744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sticky penicillin allergy labels: Assessing rates of penicillin allergy relabeling after negative testing in children.
    Olds GD; Chow TG
    Ann Allergy Asthma Immunol; 2024 May; 132(5):654-655. PubMed ID: 38246559
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-Term Follow-Up After Penicillin Allergy Delabeling in Ambulatory Patients.
    Lachover-Roth I; Sharon S; Rosman Y; Meir-Shafrir K; Confino-Cohen R
    J Allergy Clin Immunol Pract; 2019 Jan; 7(1):231-235.e1. PubMed ID: 29800754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proactive management of penicillin and other antibiotic allergies.
    Khan DA
    Allergy Asthma Proc; 2020 Mar; 41(2):82-89. PubMed ID: 32122444
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral Challenge without Skin Testing Safely Excludes Clinically Significant Delayed-Onset Penicillin Hypersensitivity.
    Confino-Cohen R; Rosman Y; Meir-Shafrir K; Stauber T; Lachover-Roth I; Hershko A; Goldberg A
    J Allergy Clin Immunol Pract; 2017; 5(3):669-675. PubMed ID: 28483317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Proactive Approach to Penicillin Allergy Testing in Hospitalized Patients.
    Chen JR; Tarver SA; Alvarez KS; Tran T; Khan DA
    J Allergy Clin Immunol Pract; 2017; 5(3):686-693. PubMed ID: 27888034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-risk penicillin allergy delabeling through a direct oral challenge in immunocompromised and/or multiple drug allergy labeled patients in a critical care setting.
    Koo G; Stollings JL; Lindsell C; Dear ML; Kripalani S; Nelson GE; McCoy AB; Rice TW; Phillips EJ; Stone CA;
    J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1660-1663.e2. PubMed ID: 35131513
    [No Abstract]   [Full Text] [Related]  

  • 20. Leading the way in penicillin allergy evaluation.
    Redmond M
    Ann Allergy Asthma Immunol; 2020 Dec; 125(6):624-625. PubMed ID: 33218454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.